HK1095285A1 - Benzamidine derivatives for treatment and prevention of mucositis - Google Patents

Benzamidine derivatives for treatment and prevention of mucositis

Info

Publication number
HK1095285A1
HK1095285A1 HK07102608.3A HK07102608A HK1095285A1 HK 1095285 A1 HK1095285 A1 HK 1095285A1 HK 07102608 A HK07102608 A HK 07102608A HK 1095285 A1 HK1095285 A1 HK 1095285A1
Authority
HK
Hong Kong
Prior art keywords
mucositis
benzamidine derivatives
prevention
treatment
epitelium
Prior art date
Application number
HK07102608.3A
Other languages
English (en)
Inventor
Ornella Letari
Massimo Maria D'amato
Simona Zanzola
Roberto Artusi
Lucio Claudio Rovati
Gianfranco Caselli
Antonio Giordani
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Publication of HK1095285A1 publication Critical patent/HK1095285A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
HK07102608.3A 2005-03-24 2007-03-09 Benzamidine derivatives for treatment and prevention of mucositis HK1095285A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102423A EP1704860B1 (en) 2005-03-24 2005-03-24 Benzamidine derivatives for treatment and prevention of mucositis

Publications (1)

Publication Number Publication Date
HK1095285A1 true HK1095285A1 (en) 2007-05-04

Family

ID=35058092

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07102608.3A HK1095285A1 (en) 2005-03-24 2007-03-09 Benzamidine derivatives for treatment and prevention of mucositis

Country Status (13)

Country Link
US (1) US20080194877A1 (pt)
EP (1) EP1704860B1 (pt)
JP (1) JP5020227B2 (pt)
AT (1) ATE485819T1 (pt)
AU (1) AU2006226390B2 (pt)
CA (1) CA2600773C (pt)
DE (1) DE602005024357D1 (pt)
DK (1) DK1704860T3 (pt)
ES (1) ES2351665T3 (pt)
HK (1) HK1095285A1 (pt)
PL (1) PL1704860T3 (pt)
PT (1) PT1704860E (pt)
WO (1) WO2006100204A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
WO2012158672A2 (en) 2011-05-16 2012-11-22 Polymedix, Inc. Compounds for use in treatment of mucositis
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
CN104583182A (zh) * 2012-05-23 2015-04-29 塞利克斯比奥私人有限公司 用于治疗粘膜炎的组合物和方法
CN105530930A (zh) 2013-08-19 2016-04-27 Enzychem生命科学株式会社 含有以单乙酰基二酰基甘油化合物作为有效成分的类风湿性关节炎的预防或者治疗用组合物
KR20180015297A (ko) 2014-05-15 2018-02-12 주식회사 엔지켐생명과학 백혈구 감소증 및 혈소판 감소증에 대한 치료 방법
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc History of urea which can be used to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458777B1 (en) * 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
ITTO20010110A1 (it) * 2001-02-08 2002-08-08 Rotta Research Lab Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.

Also Published As

Publication number Publication date
WO2006100204A1 (en) 2006-09-28
CA2600773A1 (en) 2006-09-28
PL1704860T3 (pl) 2011-04-29
ES2351665T3 (es) 2011-02-09
US20080194877A1 (en) 2008-08-14
JP5020227B2 (ja) 2012-09-05
EP1704860A1 (en) 2006-09-27
JP2008534471A (ja) 2008-08-28
AU2006226390B2 (en) 2011-09-08
ATE485819T1 (de) 2010-11-15
DE602005024357D1 (de) 2010-12-09
PT1704860E (pt) 2010-11-16
EP1704860B1 (en) 2010-10-27
CA2600773C (en) 2013-06-11
DK1704860T3 (da) 2011-02-07
AU2006226390A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
HK1095285A1 (en) Benzamidine derivatives for treatment and prevention of mucositis
WO2004093831A3 (en) Cytokine-expressing cellular vaccine combinations
WO2004073630A3 (en) Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
HK1112579A1 (en) Dosage regimen for the treatment of a traumatic brain injury with progesterone
WO2016025635A3 (en) Combination therapy for treating cancer
IL190295A0 (en) Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders
AU2003249356A8 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
WO2000035475A3 (de) Verfahren zur behandlung von cerebralen ischämien sowie verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
WO2016043874A3 (en) Combination therapy for treating cancer
EP4327873A3 (en) Tpp1 formulations and methods for treating cln2 disease
ZA200703697B (en) Use of ranolazone in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
IL307201A (en) Triazine derivatives and their use in cancer treatment.
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a C5-related disease and a method for the treatment or prevention of a C5-related disease
EP1865954A4 (en) METHOD FOR AVOIDING OEDEM IN THE TREATMENT OR PREVENTION OF DISEASES AFFECTING PPAR GAMMA INCLUDING CANCER
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
BRPI0503827A (pt) métodos para prevenir ou tratar infecções respiratórias em lactentes
IL282718A (en) Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
GB0427637D0 (en) Topical formulations for use in the treatment or prevention of skin cancers
TW200509925A (en) Method comprising irinotecan for treatment of breast cancer
IL197035A0 (en) Pharmaceutical formula for treating skin disease

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150324